Breast MRI for cancer detection and characterization: A review of evidence-based clinical applications

被引:71
作者
DeMartini, Wendy [1 ]
Lehman, Constance
Partridge, Savannah
机构
[1] Univ Washington, Med Ctr, Seattle, WA 98195 USA
[2] Seattle Canc Care Alliance, Seattle, WA USA
关键词
breast cancer; magnetic resonance imaging;
D O I
10.1016/j.acra.2007.11.006
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Rationale and Objectives. Breast MRI is an important new tool in the imaging armamentarium for the detection and characterization of breast carcinoma. Understanding the evidence-supported benefits and potential harms of breast MRI is important to ensure the appropriate utilization of this medical resource. Materials and Methods. This article reviews the clinical settings in which MRI for breast cancer assessment has been shown to be advantageous. The evidence regarding the diagnostic accuracy of MRI and the impact of this imaging tool on clinical outcomes are described. Novel breast MRI techniques which may lead to future improvements in performance are discussed. Results. Breast MRI has been shown in multiple studies to be advantageous for screening patients at high risk, evaluating patients with a new breast cancer diagnosis, monitoring treatment response in patients undergoing neoadjuvant chemotherapy and evaluating patients with metastatic axillary adenocarcinoma and unknown primary site. Among the limitations of MRI are its high cost and modest specificity resulting in false positive examinations. Conclusions. When used in evidence-supported clinical settings, the high sensitivity of MRI results in earlier cancer detection or greater accuracy of detection compared to existing tests for breast carcinoma. Further scientific endeavors are crucial to optimize the future performance and application of breast MRI.
引用
收藏
页码:408 / 416
页数:9
相关论文
共 72 条
[1]  
Abraham DC, 1996, CANCER, V78, P91, DOI 10.1002/(SICI)1097-0142(19960701)78:1<91::AID-CNCR14>3.0.CO
[2]  
2-2
[3]  
American College of Radiology (ACR), 2003, ACR Breast Imaging Reporting and Data System: Breast Imaging Atlas, V4th ed.
[4]   Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI [J].
Balu-Maestro, C ;
Chapellier, C ;
Bleuse, A ;
Chanalet, I ;
Chauvel, C ;
Largillier, R .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 72 (02) :145-152
[5]   Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging [J].
Bedrosian, I ;
Mick, R ;
Orel, SG ;
Schnall, M ;
Reynolds, C ;
Spitz, FR ;
Callans, LS ;
Buzby, GP ;
Rosato, EF ;
Fraker, DL ;
Czerniecki, BJ .
CANCER, 2003, 98 (03) :468-473
[6]   Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer [J].
Berg, WA ;
Gutierrez, L ;
NessAiver, MS ;
Carter, WB ;
Bhargavan, M ;
Lewis, RS ;
Ioffe, OB .
RADIOLOGY, 2004, 233 (03) :830-849
[7]   Magnetic resonance imaging of the breast prior to biopsy [J].
Bluemke, DA ;
Gatsonis, CA ;
Chen, MH ;
DeAngelis, GA ;
DeBruhl, N ;
Harms, S ;
Heywang-Köbrunner, SH ;
Hylton, N ;
Kuhl, CK ;
Lehman, C ;
Pisano, ED ;
Causer, P ;
Schnitt, SJ ;
Smazal, SF ;
Stelling, CB ;
Weatherall, PT ;
Schnall, MD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (22) :2735-2742
[8]   Utility of breast magnetic resonance imaging in patients with occult primary breast cancer [J].
Buchanan, CL ;
Morris, EA ;
Dorn, PL ;
Borgen, PI ;
Van Zee, KJ .
ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (12) :1045-1053
[9]   Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy [J].
Chen, XM ;
Moore, MO ;
Lehman, CD ;
Mankoff, DA ;
Lawton, TJ ;
Peacock, S ;
Schubert, EK ;
Livingston, RB .
ACADEMIC RADIOLOGY, 2004, 11 (10) :1115-1124
[10]   Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors [J].
Chenevert, TL ;
Stegman, LD ;
Taylor, JMG ;
Robertson, PL ;
Greenberg, HS ;
Rehemtulla, A ;
Ross, BD .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (24) :2029-2036